At-home Breast Oncology care Delivered with E-Health solutions - The ABODE Study
- Funded by Canadian Institutes of Health Research (CIHR)
- Total publications:0 publications
Grant number: 202104PNN
Grant search
Key facts
Disease
COVID-19Start & end year
20212022Known Financial Commitments (USD)
$0Funder
Canadian Institutes of Health Research (CIHR)Research Location
CanadaLead Research Institution
University Health NetworkResearch Priority Alignment
N/A
Research Category
Secondary impacts of disease, response & control measuresResearch Subcategory
Indirect health impactsSpecial Interest Tags
Digital HealthStudy Type
ClinicalClinical Trial Details
Randomized Controlled TrialBroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified
Abstract
The COVID-19 pandemic has significantly impacted healthcare service delivery, highlighting the need for high quality virtual patient care. We have developed a multi-dimensional remote patient eHealth solution for newly diagnosed breast cancer patients and their practitioners to use during the diagnostic and surgical follow-up period. We have developed the Breast Cancer Treatment Application (BCTA) that can facilitate virtual consultations, deliver patient education material, and collect patient reported outcome measures. Using a randomized controlled trial design across three sites, we will evaluate a variety of outcomes for breast cancer patients who will use the BCTA through their diagnosis and treatment. Our study will compare changes in patient activation over 1 year among newly diagnosed breast cancer patients between those using the BCTA and those receiving standard care. We will also evaluate anxiety, psychosocial well-being and quality of life between the two groups. To further understand the impact of the BCTA, we will assess the health services utilization and patient satisfaction outcomes. Our innovation will provide a solution to improve communication between patients and their healthcare providers.